Central African Republic vs El Salvador: Access to anti-retroviral drugs, female
Central African Republic
73.0%
in 2024
El Salvador
74.0%
in 2024
Central African Republic rank
71st
El Salvador rank
69th
Access to anti-retroviral drugs, female over time
- Central African Republic
- El Salvador
How they compare
El Salvador currently reports 74.0% against 73.0% in Central African Republic, a difference of 1.0%.
Across all 25 years both countries report, El Salvador has been ahead every year.
Central African Republic ranks 71st and El Salvador ranks 69th of 141 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central African Republic | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.4% | 11.9% | 9.5% | El Salvador |
| 2010s | 26.1% | 64.3% | 38.2% | El Salvador |
| 2020s | 65.6% | 74.2% | 8.6% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Central African Republic or El Salvador?
- El Salvador, at 74.0% against 73.0% in Central African Republic as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Central African Republic and El Salvador?
- 1.0%, with El Salvador ahead.
- How many years of comparable data are there for Central African Republic and El Salvador?
- 25 years are reported by both, from 2000 to 2024.
- How do Central African Republic and El Salvador rank globally for access to anti-retroviral drugs, female?
- Central African Republic ranks 71st and El Salvador ranks 69th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.